Dexcom, Inc. is a leading multinational medical device company specializing in continuous glucose monitoring (CGM) systems for people with diabetes. Founded in 1999 and headquartered in San Diego, California, Dexcom has revolutionized diabetes management by providing real-time glucose readings, trend data, and alerts that empower patients and healthcare providers to make informed treatment decisions. The company's mission is to help people manage diabetes more effectively and improve quality of life through innovative technology and actionable insights.
With over 8,000 employees worldwide, Dexcom is recognized as a pioneer in the CGM market and holds a strong competitive position against other major players in the diabetes care industry. Its flagship products, such as the Dexcom G6 and G7 systems, have set high standards for accuracy, convenience, and connectivity, integrating with smartphones, insulin pumps, and digital health platforms. In recent years, Dexcom has expanded its global footprint, launched next-generation devices, and reported significant growth in revenue and user adoption. The company continues to invest heavily in research and development to advance CGM technology and broaden access to its solutions.